19,612 Axon Enterprise, Inc $AXON Shares Sold by Fifth Third Bancorp

Fifth Third Bancorp cut its position in Axon Enterprise, Inc (NASDAQ:AXON) by 1.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,303,883 shares of the biotechnology company’s stock after selling 19,612 shares during the quarter. Axon Enterprise makes up 0.9% of Fifth Third Bancorp’s investment portfolio, making the stock its 18th biggest holding. Fifth Third Bancorp owned about 1.60% of Axon Enterprise worth $550,917,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the company. M & L Capital Management Ltd purchased a new stake in Axon Enterprise in the third quarter valued at approximately $30,000. Keating Financial Advisory Services Inc. acquired a new stake in shares of Axon Enterprise in the second quarter valued at approximately $31,000. Wealth Enhancement Trust Services Inc. purchased a new position in shares of Axon Enterprise during the third quarter worth approximately $33,000. Putney Financial Group LLC purchased a new position in shares of Axon Enterprise during the third quarter worth approximately $36,000. Finally, Washington Trust Advisors Inc. grew its position in shares of Axon Enterprise by 1,300.0% during the second quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock worth $39,000 after acquiring an additional 65 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on AXON shares. JPMorgan Chase & Co. cut their target price on shares of Axon Enterprise from $755.00 to $610.00 and set an “overweight” rating on the stock in a report on Friday, November 6th. Royal Bank Of Canada decreased their price target on shares of Axon Enterprise from $735.00 to $615.00 and set an “outperform” rating for the company in a research note on Friday, November 6th. TD Cowen lowered their price objective on shares of Axon Enterprise from $825.00 to $800.00 and set a “buy” rating on the stock in a research report on Monday, October 26th. Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a research report on Tuesday, November 3rd. Finally, Needham & Company LLC dropped their price objective on shares of Axon Enterprise from $750.00 to $500.00 and set a “buy” rating on the stock in a research note on Friday, November 6th. Thirteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $612.18.

Key Stories Impacting Axon Enterprise

Here are a few of the latest stories about AXON:

• Positive Sentiment: Axon’s integrated public-safety hardware and software ecosystem, along with continued revenue growth, are cited as reasons it could remain a long-term growth company despite its 2026 share-price decline. 3 Superior Growth Stocks That Can Outperform for the Next 10 Years
• Negative Sentiment: Axon’s third-quarter adjusted EPS missed Wall Street expectations, and cautious guidance contributed to a sharp share decline. The company also said federal contract delays shifted $130 million of revenue out of 2026, weighing on near-term expectations. Axon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?
• Negative Sentiment: Several law firms have announced investigations into potential securities-law claims related to Axon’s earnings report. These are allegations under investigation, not findings of wrongdoing, but add a source of uncertainty for investors. Levi & Korsinsky investor investigation notice

Axon Enterprise Stock Up 4.3%

Axon Enterprise stock opened at $315.42 on Thursday. The stock has a 50 day moving average of $426.24 and a two-hundred day moving average of $470.65. Axon Enterprise, Inc has a twelve month low of $291.45 and a twelve month high of $665.07. The stock has a market capitalization of $25.68 billion, a price-to-earnings ratio of 101.10, a PEG ratio of 5.75 and a beta of 1.48. The company has a current ratio of 3.00, a quick ratio of 2.60 and a debt-to-equity ratio of 0.76.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The company had revenue of $908.55 million during the quarter, compared to analyst estimates of $934.33 million. During the same period in the previous year, the firm posted $1.17 EPS. The company’s revenue for the quarter was up 27.8% on a year-over-year basis. As a group, research analysts expect that Axon Enterprise, Inc will post 2.10 earnings per share for the current year.

Insider Buying and Selling

In other Axon Enterprise news, President Joshua Isner sold 16,775 shares of the business’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $574.43, for a total value of $9,636,063.25. Following the transaction, the president directly owned 296,974 shares of the company’s stock, valued at approximately $170,590,774.82. The trade was a 5.35% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the transaction, the chief executive officer owned 3,118,012 shares of the company’s stock, valued at approximately $1,587,036,927.88. The trade was a 0.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 37,397 shares of company stock valued at $21,234,034 in the last ninety days. Company insiders own 4.20% of the company’s stock.

About Axon Enterprise

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.